The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

by Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé
Published 2021-03-01

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?

by Sebastiaan HC Klaassen, Dirk J van Veldhuisen, Hans LA Nienhuis, Maarten P van den Berg, Bouke PC Hazenberg, Peter van der Meer
Published 2020-08-01

Inflammation aggravates disease severity in Marfan syndrome patients.

by Teodora Radonic, Piet de Witte, Maarten Groenink, Vivian de Waard, Rene Lutter, Marco van Eijk, Marnix Jansen, Janneke Timmermans, Marlies Kempers, Arthur J Scholte, Yvonne Hilhorst-Hofstee, Maarten P van den Berg, J Peter van Tintelen, Gerard Pals, Marieke J H Baars, Barbara J M Mulder, Aeilko H Zwinderman
Published 2012-01-01

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

by Edgar T Hoorntje, Anna Posafalvi, Petros Syrris, K Joeri van der Velde, Marieke C Bolling, Alexandros Protonotarios, Ludolf G Boven, Nuria Amat-Codina, Judith A Groeneweg, Arthur A Wilde, Nara Sobreira, Hugh Calkins, Richard N W Hauer, Marcel F Jonkman, William J McKenna, Perry M Elliott, Richard J Sinke, Maarten P van den Berg, Stephen P Chelko, Cynthia A James, J Peter van Tintelen, Daniel P Judge, Jan D H Jongbloed
Published 2018-01-01